Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 235 entries
Sorted by: Best Match Show Resources per page
Correction.

Circulation. Heart failure

[No authors listed]
PMID: 26920217
Circ Heart Fail. 2016 Mar;9(3):e000014. doi: 10.1161/HHF.0000000000000014.

No abstract available.

Cite
Correction. Circ Heart Fail. 2016;9(3):e000014doi: 10.1161/HHF.0000000000000014.
(2016). Correction. Circulation. Heart failure, 9(3), e000014. https://doi.org/10.1161/HHF.0000000000000014
"Correction." Circulation. Heart failure vol. 9,3 (2016): e000014. doi: https://doi.org/10.1161/HHF.0000000000000014
Correction. Circ Heart Fail. 2016 Mar;9(3):e000014. doi: 10.1161/HHF.0000000000000014. PMID: 26920217.
Copy Download .nbib Format: NLM
Most important articles in heart failure in children.

Circulation. Heart failure

Kociol RD.
PMID: 24255058
Circ Heart Fail. 2013 Nov;6(6):e73-9. doi: 10.1161/CIRCHEARTFAILURE.113.000917.

No abstract available.

Cite
Kociol RD. Most important articles in heart failure in children. Circ Heart Fail. 2013;6(6):e73-9doi: 10.1161/CIRCHEARTFAILURE.113.000917.
Kociol, R. D. (2013). Most important articles in heart failure in children. Circulation. Heart failure, 6(6), e73-9. https://doi.org/10.1161/CIRCHEARTFAILURE.113.000917
Kociol, Robb D. "Most important articles in heart failure in children." Circulation. Heart failure vol. 6,6 (2013): e73-9. doi: https://doi.org/10.1161/CIRCHEARTFAILURE.113.000917
Kociol RD. Most important articles in heart failure in children. Circ Heart Fail. 2013 Nov;6(6):e73-9. doi: 10.1161/CIRCHEARTFAILURE.113.000917. PMID: 24255058.
Copy Download .nbib Format: NLM
Correction to: Symptom Diary Use and Improved Survival for Patients With Heart Failure.

Circulation. Heart failure

[No authors listed]
PMID: 29203561
Circ Heart Fail. 2017 Dec;10(12). doi: 10.1161/HHF.0000000000000025.

No abstract available.

Cite
Correction to: Symptom Diary Use and Improved Survival for Patients With Heart Failure. Circ Heart Fail. 2017;10(12)doi: 10.1161/HHF.0000000000000025.
(2017). Correction to: Symptom Diary Use and Improved Survival for Patients With Heart Failure. Circulation. Heart failure, 10(12), . https://doi.org/10.1161/HHF.0000000000000025
"Correction to: Symptom Diary Use and Improved Survival for Patients With Heart Failure." Circulation. Heart failure vol. 10,12 (2017). doi: https://doi.org/10.1161/HHF.0000000000000025
Correction to: Symptom Diary Use and Improved Survival for Patients With Heart Failure. Circ Heart Fail. 2017 Dec;10(12). doi: 10.1161/HHF.0000000000000025. PMID: 29203561.
Copy Download .nbib Format: NLM
Correction to: HeartLogic Multisensor Algorithm Identifies Patients During Periods of Significantly Increased Risk of Heart Failure Events: Results From the MultiSENSE Study.

Circulation. Heart failure

[No authors listed]
PMID: 30354568
Circ Heart Fail. 2018 Aug;11(8):e000029. doi: 10.1161/HHF.0000000000000029.

No abstract available.

Cite
Correction to: HeartLogic Multisensor Algorithm Identifies Patients During Periods of Significantly Increased Risk of Heart Failure Events: Results From the MultiSENSE Study. Circ Heart Fail. 2018;11(8):e000029doi: 10.1161/HHF.0000000000000029.
(2018). Correction to: HeartLogic Multisensor Algorithm Identifies Patients During Periods of Significantly Increased Risk of Heart Failure Events: Results From the MultiSENSE Study. Circulation. Heart failure, 11(8), e000029. https://doi.org/10.1161/HHF.0000000000000029
"Correction to: HeartLogic Multisensor Algorithm Identifies Patients During Periods of Significantly Increased Risk of Heart Failure Events: Results From the MultiSENSE Study." Circulation. Heart failure vol. 11,8 (2018): e000029. doi: https://doi.org/10.1161/HHF.0000000000000029
Correction to: HeartLogic Multisensor Algorithm Identifies Patients During Periods of Significantly Increased Risk of Heart Failure Events: Results From the MultiSENSE Study. Circ Heart Fail. 2018 Aug;11(8):e000029. doi: 10.1161/HHF.0000000000000029. PMID: 30354568.
Copy Download .nbib Format: NLM
Correction to: Omega-3 Therapy Is Associated With Reduced Gastrointestinal Bleeding in Patients With Continuous-Flow Left Ventricular Assist Device.

Circulation. Heart failure

[No authors listed]
PMID: 30525988
Circ Heart Fail. 2018 Nov;11(11):e000030. doi: 10.1161/HHF.0000000000000030.

No abstract available.

Cite
Correction to: Omega-3 Therapy Is Associated With Reduced Gastrointestinal Bleeding in Patients With Continuous-Flow Left Ventricular Assist Device. Circ Heart Fail. 2018;11(11):e000030doi: 10.1161/HHF.0000000000000030.
(2018). Correction to: Omega-3 Therapy Is Associated With Reduced Gastrointestinal Bleeding in Patients With Continuous-Flow Left Ventricular Assist Device. Circulation. Heart failure, 11(11), e000030. https://doi.org/10.1161/HHF.0000000000000030
"Correction to: Omega-3 Therapy Is Associated With Reduced Gastrointestinal Bleeding in Patients With Continuous-Flow Left Ventricular Assist Device." Circulation. Heart failure vol. 11,11 (2018): e000030. doi: https://doi.org/10.1161/HHF.0000000000000030
Correction to: Omega-3 Therapy Is Associated With Reduced Gastrointestinal Bleeding in Patients With Continuous-Flow Left Ventricular Assist Device. Circ Heart Fail. 2018 Nov;11(11):e000030. doi: 10.1161/HHF.0000000000000030. PMID: 30525988.
Copy Download .nbib Format: NLM
Safety of Endomyocardial Biopsy in New-Onset Acute Heart Failure Requiring Veno-Arterial Extracorporeal Membrane Oxygenation.

Circulation. Heart failure

van der Boon RMA, den Dekker WK, Meuwese CL, Lorusso R, von der Thüsen JH, Constantinescu AC, Manintveld OC, Delnoij TSR, van der Heijden JJ, van Mieghem NMDA, den Uil CA.
PMID: 34344163
Circ Heart Fail. 2021 Aug;14(8):e008387. doi: 10.1161/CIRCHEARTFAILURE.121.008387. Epub 2021 Aug 04.

BACKGROUND: Endomyocardial biopsy (EMB) has an important role in determining the pathogenesis of new-onset acute heart failure (new-AHF) when noninvasive testing is impossible. However, data on safety and histopathologic outcomes in patients requiring veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is...

Cite
van der Boon RMA, den Dekker WK, Meuwese CL, et al. Safety of Endomyocardial Biopsy in New-Onset Acute Heart Failure Requiring Veno-Arterial Extracorporeal Membrane Oxygenation. Circ Heart Fail. 2021;14(8):e008387doi: 10.1161/CIRCHEARTFAILURE.121.008387.
van der Boon, R. M. A., den Dekker, W. K., Meuwese, C. L., Lorusso, R., von der Thüsen, J. H., Constantinescu, A. C., Manintveld, O. C., Delnoij, T. S. R., van der Heijden, J. J., van Mieghem, N. M. D. A., & den Uil, C. A. (2021). Safety of Endomyocardial Biopsy in New-Onset Acute Heart Failure Requiring Veno-Arterial Extracorporeal Membrane Oxygenation. Circulation. Heart failure, 14(8), e008387. https://doi.org/10.1161/CIRCHEARTFAILURE.121.008387
van der Boon, Robert M A, et al. "Safety of Endomyocardial Biopsy in New-Onset Acute Heart Failure Requiring Veno-Arterial Extracorporeal Membrane Oxygenation." Circulation. Heart failure vol. 14,8 (2021): e008387. doi: https://doi.org/10.1161/CIRCHEARTFAILURE.121.008387
van der Boon RMA, den Dekker WK, Meuwese CL, Lorusso R, von der Thüsen JH, Constantinescu AC, Manintveld OC, Delnoij TSR, van der Heijden JJ, van Mieghem NMDA, den Uil CA. Safety of Endomyocardial Biopsy in New-Onset Acute Heart Failure Requiring Veno-Arterial Extracorporeal Membrane Oxygenation. Circ Heart Fail. 2021 Aug;14(8):e008387. doi: 10.1161/CIRCHEARTFAILURE.121.008387. Epub 2021 Aug 04. PMID: 34344163.
Copy Download .nbib Format: NLM
Acute Hemodynamic Effects and Tolerability of Phosphodiesterase-1 Inhibition With ITI-214 in Human Systolic Heart Failure.

Circulation. Heart failure

Gilotra NA, DeVore AD, Povsic TJ, Hays AG, Hahn VS, Agunbiade TA, DeLong A, Satlin A, Chen R, Davis R, Kass DA.
PMID: 34461742
Circ Heart Fail. 2021 Sep;14(9):e008236. doi: 10.1161/CIRCHEARTFAILURE.120.008236. Epub 2021 Aug 31.

BACKGROUND: PDE1 (phosphodiesterase type 1) hydrolyzes cyclic adenosine and guanosine monophosphate. ITI-214 is a highly selective PDE1 inhibitor that induces arterial vasodilation and positive inotropy in larger mammals. Here, we assessed pharmacokinetics, hemodynamics, and tolerability of single-dose ITI-214 in...

Cite
Gilotra NA, DeVore AD, Povsic TJ, et al. Acute Hemodynamic Effects and Tolerability of Phosphodiesterase-1 Inhibition With ITI-214 in Human Systolic Heart Failure. Circ Heart Fail. 2021;14(9):e008236doi: 10.1161/CIRCHEARTFAILURE.120.008236.
Gilotra, N. A., DeVore, A. D., Povsic, T. J., Hays, A. G., Hahn, V. S., Agunbiade, T. A., DeLong, A., Satlin, A., Chen, R., Davis, R., & Kass, D. A. (2021). Acute Hemodynamic Effects and Tolerability of Phosphodiesterase-1 Inhibition With ITI-214 in Human Systolic Heart Failure. Circulation. Heart failure, 14(9), e008236. https://doi.org/10.1161/CIRCHEARTFAILURE.120.008236
Gilotra, Nisha A, et al. "Acute Hemodynamic Effects and Tolerability of Phosphodiesterase-1 Inhibition With ITI-214 in Human Systolic Heart Failure." Circulation. Heart failure vol. 14,9 (2021): e008236. doi: https://doi.org/10.1161/CIRCHEARTFAILURE.120.008236
Gilotra NA, DeVore AD, Povsic TJ, Hays AG, Hahn VS, Agunbiade TA, DeLong A, Satlin A, Chen R, Davis R, Kass DA. Acute Hemodynamic Effects and Tolerability of Phosphodiesterase-1 Inhibition With ITI-214 in Human Systolic Heart Failure. Circ Heart Fail. 2021 Sep;14(9):e008236. doi: 10.1161/CIRCHEARTFAILURE.120.008236. Epub 2021 Aug 31. PMID: 34461742; PMCID: PMC8458252.
Copy Download .nbib Format: NLM
Untangling the Sex-Frailty Paradox in Heart Failure.

Circulation. Heart failure

Flint K.
PMID: 34428918
Circ Heart Fail. 2021 Sep;14(9):e008860. doi: 10.1161/CIRCHEARTFAILURE.121.008860. Epub 2021 Aug 25.

No abstract available.

Cite
Flint K. Untangling the Sex-Frailty Paradox in Heart Failure. Circ Heart Fail. 2021;14(9):e008860doi: 10.1161/CIRCHEARTFAILURE.121.008860.
Flint, K. (2021). Untangling the Sex-Frailty Paradox in Heart Failure. Circulation. Heart failure, 14(9), e008860. https://doi.org/10.1161/CIRCHEARTFAILURE.121.008860
Flint, Kelsey. "Untangling the Sex-Frailty Paradox in Heart Failure." Circulation. Heart failure vol. 14,9 (2021): e008860. doi: https://doi.org/10.1161/CIRCHEARTFAILURE.121.008860
Flint K. Untangling the Sex-Frailty Paradox in Heart Failure. Circ Heart Fail. 2021 Sep;14(9):e008860. doi: 10.1161/CIRCHEARTFAILURE.121.008860. Epub 2021 Aug 25. PMID: 34428918.
Copy Download .nbib Format: NLM
Potential Novel Therapeutic Target to Improve Graft Survival: New Insights Into the Role of Checkpoint Molecules in Heart Transplant Rejection.

Circulation. Heart failure

Heidecker B.
PMID: 34634915
Circ Heart Fail. 2021 Oct;14(10):e008859. doi: 10.1161/CIRCHEARTFAILURE.121.008859. Epub 2021 Oct 12.

No abstract available.

Cite
Heidecker B. Potential Novel Therapeutic Target to Improve Graft Survival: New Insights Into the Role of Checkpoint Molecules in Heart Transplant Rejection. Circ Heart Fail. 2021;14(10):e008859doi: 10.1161/CIRCHEARTFAILURE.121.008859.
Heidecker, B. (2021). Potential Novel Therapeutic Target to Improve Graft Survival: New Insights Into the Role of Checkpoint Molecules in Heart Transplant Rejection. Circulation. Heart failure, 14(10), e008859. https://doi.org/10.1161/CIRCHEARTFAILURE.121.008859
Heidecker, Bettina. "Potential Novel Therapeutic Target to Improve Graft Survival: New Insights Into the Role of Checkpoint Molecules in Heart Transplant Rejection." Circulation. Heart failure vol. 14,10 (2021): e008859. doi: https://doi.org/10.1161/CIRCHEARTFAILURE.121.008859
Heidecker B. Potential Novel Therapeutic Target to Improve Graft Survival: New Insights Into the Role of Checkpoint Molecules in Heart Transplant Rejection. Circ Heart Fail. 2021 Oct;14(10):e008859. doi: 10.1161/CIRCHEARTFAILURE.121.008859. Epub 2021 Oct 12. PMID: 34634915.
Copy Download .nbib Format: NLM
SARS-CoV-2-Associated Myocarditis: A Case of Direct Myocardial Injury.

Circulation. Heart failure

Verma AK, Olagoke O, Moreno JD, Rezaee N, Ma P, Liu J, Javaheri A, Lavine K, Masood MF, Lin CY.
PMID: 35012323
Circ Heart Fail. 2022 Jan 11;CIRCHEARTFAILURE120008273. doi: 10.1161/CIRCHEARTFAILURE.120.008273. Epub 2022 Jan 11.

No abstract available.

Cite
Verma AK, Olagoke O, Moreno JD, et al. SARS-CoV-2-Associated Myocarditis: A Case of Direct Myocardial Injury. Circ Heart Fail. 2022;CIRCHEARTFAILURE120008273doi: 10.1161/CIRCHEARTFAILURE.120.008273.
Verma, A. K., Olagoke, O., Moreno, J. D., Rezaee, N., Ma, P., Liu, J., Javaheri, A., Lavine, K., Masood, M. F., & Lin, C. Y. (2022). SARS-CoV-2-Associated Myocarditis: A Case of Direct Myocardial Injury. Circulation. Heart failure, CIRCHEARTFAILURE120008273. https://doi.org/10.1161/CIRCHEARTFAILURE.120.008273
Verma, Amanda K, et al. "SARS-CoV-2-Associated Myocarditis: A Case of Direct Myocardial Injury." Circulation. Heart failure vol. (2022): CIRCHEARTFAILURE120008273. doi: https://doi.org/10.1161/CIRCHEARTFAILURE.120.008273
Verma AK, Olagoke O, Moreno JD, Rezaee N, Ma P, Liu J, Javaheri A, Lavine K, Masood MF, Lin CY. SARS-CoV-2-Associated Myocarditis: A Case of Direct Myocardial Injury. Circ Heart Fail. 2022 Jan 11;CIRCHEARTFAILURE120008273. doi: 10.1161/CIRCHEARTFAILURE.120.008273. Epub 2022 Jan 11. PMID: 35012323.
Copy Download .nbib Format: NLM
Multiparametric Implantable Cardioverter-Defibrillator Algorithm for Heart Failure Risk Stratification and Management: An Analysis in Clinical Practice.

Circulation. Heart failure

Calò L, Bianchi V, Ferraioli D, Santini L, Dello Russo A, Carriere C, Santobuono VE, Andreoli C, La Greca C, Arena G, Talarico A, Pisanò E, Santoro A, Giammaria M, Ziacchi M, Viscusi M, De Ruvo E, Campari M, Valsecchi S, D'Onofrio A.
PMID: 34190592
Circ Heart Fail. 2021 Oct;14(10):e008134. doi: 10.1161/CIRCHEARTFAILURE.120.008134. Epub 2021 Jun 30.

BACKGROUND: The HeartLogic algorithm combines multiple implantable cardioverter-defibrillator sensors to identify patients at risk of heart failure (HF) events. We sought to evaluate the risk stratification ability of this algorithm in clinical practice. We also analyzed the alert management...

Cite
Calò L, Bianchi V, Ferraioli D, et al. Multiparametric Implantable Cardioverter-Defibrillator Algorithm for Heart Failure Risk Stratification and Management: An Analysis in Clinical Practice. Circ Heart Fail. 2021;14(10):e008134doi: 10.1161/CIRCHEARTFAILURE.120.008134.
Calò, L., Bianchi, V., Ferraioli, D., Santini, L., Dello Russo, A., Carriere, C., Santobuono, V. E., Andreoli, C., La Greca, C., Arena, G., Talarico, A., Pisanò, E., Santoro, A., Giammaria, M., Ziacchi, M., Viscusi, M., De Ruvo, E., Campari, M., Valsecchi, S., D'Onofrio, A. (2021). Multiparametric Implantable Cardioverter-Defibrillator Algorithm for Heart Failure Risk Stratification and Management: An Analysis in Clinical Practice. Circulation. Heart failure, 14(10), e008134. https://doi.org/10.1161/CIRCHEARTFAILURE.120.008134
Calò, Leonardo, et al. "Multiparametric Implantable Cardioverter-Defibrillator Algorithm for Heart Failure Risk Stratification and Management: An Analysis in Clinical Practice." Circulation. Heart failure vol. 14,10 (2021): e008134. doi: https://doi.org/10.1161/CIRCHEARTFAILURE.120.008134
Calò L, Bianchi V, Ferraioli D, Santini L, Dello Russo A, Carriere C, Santobuono VE, Andreoli C, La Greca C, Arena G, Talarico A, Pisanò E, Santoro A, Giammaria M, Ziacchi M, Viscusi M, De Ruvo E, Campari M, Valsecchi S, D'Onofrio A. Multiparametric Implantable Cardioverter-Defibrillator Algorithm for Heart Failure Risk Stratification and Management: An Analysis in Clinical Practice. Circ Heart Fail. 2021 Oct;14(10):e008134. doi: 10.1161/CIRCHEARTFAILURE.120.008134. Epub 2021 Jun 30. PMID: 34190592; PMCID: PMC8522625.
Copy Download .nbib Format: NLM
Use of Extracorporeal Membrane Oxygenation as Bridge to Replacement Therapies in Cardiogenic Shock: Insights From the Extracorporeal Life Support Organization.

Circulation. Heart failure

Mastoris I, Tonna JE, Hu J, Sauer AJ, Haglund NA, Rycus P, Wang Y, Wallisch WJ, Abicht TO, Danter MR, Tedford RJ, Fang JC, Shah Z.
PMID: 34879706
Circ Heart Fail. 2021 Dec 09;CIRCHEARTFAILURE121008777. doi: 10.1161/CIRCHEARTFAILURE.121.008777. Epub 2021 Dec 09.

BACKGROUND: There has been increasing use of extracorporeal membrane oxygenation (ECMO) as bridge to heart transplant (orthotopic heart transplant [OHT]) or left ventricular assist device (LVAD) over the last decade. We aimed to provide insights on the population, outcomes,...

Cite
Mastoris I, Tonna JE, Hu J, et al. Use of Extracorporeal Membrane Oxygenation as Bridge to Replacement Therapies in Cardiogenic Shock: Insights From the Extracorporeal Life Support Organization. Circ Heart Fail. 2021;CIRCHEARTFAILURE121008777doi: 10.1161/CIRCHEARTFAILURE.121.008777.
Mastoris, I., Tonna, J. E., Hu, J., Sauer, A. J., Haglund, N. A., Rycus, P., Wang, Y., Wallisch, W. J., Abicht, T. O., Danter, M. R., Tedford, R. J., Fang, J. C., & Shah, Z. (2021). Use of Extracorporeal Membrane Oxygenation as Bridge to Replacement Therapies in Cardiogenic Shock: Insights From the Extracorporeal Life Support Organization. Circulation. Heart failure, CIRCHEARTFAILURE121008777. https://doi.org/10.1161/CIRCHEARTFAILURE.121.008777
Mastoris, Ioannis, et al. "Use of Extracorporeal Membrane Oxygenation as Bridge to Replacement Therapies in Cardiogenic Shock: Insights From the Extracorporeal Life Support Organization." Circulation. Heart failure vol. (2021): CIRCHEARTFAILURE121008777. doi: https://doi.org/10.1161/CIRCHEARTFAILURE.121.008777
Mastoris I, Tonna JE, Hu J, Sauer AJ, Haglund NA, Rycus P, Wang Y, Wallisch WJ, Abicht TO, Danter MR, Tedford RJ, Fang JC, Shah Z. Use of Extracorporeal Membrane Oxygenation as Bridge to Replacement Therapies in Cardiogenic Shock: Insights From the Extracorporeal Life Support Organization. Circ Heart Fail. 2021 Dec 09;CIRCHEARTFAILURE121008777. doi: 10.1161/CIRCHEARTFAILURE.121.008777. Epub 2021 Dec 09. PMID: 34879706.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 235 entries